Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

2.4K
2.4K
Cancer Therapies02:49

Cancer Therapies

8.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K
Cancer02:18

Cancer

51.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.7K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.1K
1.1K
Metastasis02:30

Metastasis

3.3K
3.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer care and outreach in South Asian Association for Regional Cooperation (SAARC) countries: from epidemiology and the National Cancer Control Programme to screening, diagnosis, and treatment.

The Lancet. Oncology·2024
Same author

Cancer care and outreach in the South Asian Association for Regional Cooperation (SAARC) region: overcoming barriers and addressing challenges.

The Lancet. Oncology·2024
Same author

Cancer education and training within the South Asian Association for Regional Cooperation (SAARC) countries.

The Lancet. Oncology·2024
Same author

Cancer research in South Asian Association for Regional Cooperation (SAARC) countries.

The Lancet. Oncology·2024

Related Experiment Video

Updated: May 3, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K

Oncology in Nepal.

Madan K Piya1, Sandhya C Acharya1

  • 1Department of Clinical Oncology, National Cancer Hospital, Jawlakhel, Lalitpur, Nepal.

South Asian Journal of Cancer
|January 24, 2014
PubMed
Summary

Oncology in Nepal is developing slowly due to limited healthcare resources. This review examines the history, challenges, and progress of cancer care and academic training in Nepal.

Area of Science:

  • Medical Oncology
  • Public Health
  • Healthcare Systems Development

Background:

  • Nepal, a developing nation, faces significant challenges in healthcare, with oncology services in nascent stages.
  • The cancer burden in Nepal is substantial, yet access to advanced diagnosis and treatment remains limited.
  • The evolution of oncology services is crucial for improving cancer patient outcomes in low-resource settings.

Purpose of the Study:

  • To provide a historical perspective on the development of oncology in Nepal.
  • To overview the current cancer scenario and challenges in the country.
  • To highlight efforts by national and international organizations to advance cancer care and technology.

Main Methods:

  • This study is a review article.
Keywords:
Cancercancer treatmentdeveloping countryoncology

More Related Videos

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
05:30

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

Published on: October 31, 2025

459
Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications
06:42

Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications

Published on: September 2, 2025

776

Related Experiment Videos

Last Updated: May 3, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K
Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
05:30

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

Published on: October 31, 2025

459
Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications
06:42

Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications

Published on: September 2, 2025

776
  • It synthesizes information on the historical evolution of oncology in Nepal.
  • It analyzes challenges, constraints, and successes in developing oncology services.

    • Main Results:

    • Oncology in Nepal is in its early stages, mirroring the country's developing healthcare infrastructure.
    • Significant challenges exist in academic training, access to modern technology, and overall cancer care delivery.
    • Various national and international initiatives are underway to foster advancements in the field.

    Conclusions:

    • The development of oncology in Nepal requires sustained efforts to overcome resource limitations and infrastructural gaps.
    • Addressing challenges in academic training and technology adoption is vital for progress.
    • Collaborative initiatives are essential to improve cancer care and patient outcomes in Nepal.